Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
It's a research tool, not a second brain ...
Learn what Microsoft Copilot is, how it works, pricing, features, and whether it’s worth it in 2026 across Windows, Edge, and ...
One feature Obsidian can’t replicate.